Finance

Lists
Why is KAEF down 4,40%?
Dive Deeper
KAEF:IDX
Kimia Farma (Persero) Tbk PT
IDR 348,00
-4,40%
(-16,00) 1D
19 Nov., 16:02:29 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for KAEF...
Open
IDR 370
High
IDR 370
Low
IDR 342
Mkt. cap
1,94 bn.
Avg. vol.
898,29 k
Volume
945,40 k
52-wk high
IDR 785
52-wk low
IDR 324
EPS
-IDR 39
Shares outstanding
5,57 mjd.
No. of employees
9 k
Open
IDR 370
High
IDR 370
Low
IDR 342
Mkt. cap
1,94 bn.
Avg. vol.
898,29 k
Volume
945,40 k
52-wk high
IDR 785
52-wk low
IDR 324
EPS
-IDR 39
Shares outstanding
5,57 mjd.
No. of employees
9 k
News stories
From web sources and news partners
Profile
PT Kimia Farma Tbk is an Indonesian pharmaceutical producer and distributor in Indonesia. It is based in Jakarta. Wikipedia
About Kimia Farma (Persero) Tbk PT
CEO-
Employees9,22 k
Founded16 Aug. 1971
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
2,22 bn.
2,03 bn.
2,67 bn.
2,37 bn.
Cost of goods sold
1,56 bn.
1,29 bn.
1,86 bn.
1,58 bn.
Cost of revenue
1,56 bn.
1,29 bn.
1,86 bn.
1,58 bn.
Research and development expenses
7,54 mjd.
3,20 mjd.
10,39 mjd.
8,30 mjd.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
663,87 mjd.
640,94 mjd.
620,33 mjd.
611,55 mjd.
Operating expense
877,17 mjd.
669,20 mjd.
722,39 mjd.
720,62 mjd.
Total operating expenses
2,44 bn.
1,96 bn.
2,59 bn.
2,30 bn.
Operating income
-222,99 mjd.
67,93 mjd.
84,77 mjd.
69,64 mjd.
Other non operating income
173,66 mjd.
159,00 mjd.
-26,56 mjd.
-10,68 mjd.
EBT including unusual items
-223,75 mjd.
127,96 mjd.
-60,16 mjd.
-57,52 mjd.
EBT excluding unusual items
-260,76 mjd.
127,95 mjd.
-60,19 mjd.
-63,66 mjd.
Income tax expense
-14,50 mjd.
4,32 mjd.
9,40 mjd.
9,47 mjd.
Effective tax rate
6,48%
3,37%
-15,62%
-16,46%
Other operating expenses
-36,20 mjd.
-12,78 mjd.
-9,74 mjd.
6,41 mjd.
Net income
-155,23 mjd.
74,45 mjd.
-64,12 mjd.
-72,34 mjd.
Net profit margin
-7,01%
3,67%
-2,40%
-3,05%
Earnings per share
-
-
-
-
Interest and investment income
10,77 mjd.
2,87 mjd.
8,13 mjd.
7,82 mjd.
Interest expense
-221,53 mjd.
-110,15 mjd.
-125,81 mjd.
-121,69 mjd.
Net interest expenses
-210,75 mjd.
-107,28 mjd.
-117,68 mjd.
-113,87 mjd.
Depreciation and amortization charges
175,98 mjd.
37,85 mjd.
101,42 mjd.
81,08 mjd.
EBITDA
-86,40 mjd.
125,64 mjd.
165,62 mjd.
155,10 mjd.
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google-programme